← The Wire
RNANasdaq
Atrium Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 2093101
Develops RNA-based cardiac therapeutics targeting specific gene mutations for cardiomyopathies
$212M
Market cap
$13.65
Last close
+3.5%
1D
+5.5%
5D
382K
Volume
Price · last 39 sessions+6.1%
May 4L $11.55 · H $13.65Jun 29
4
Total filings
May 14, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 14, 20268-KResults of OperationsMay 14, 20268-KChange of Control · Executive ChangeFeb 27, 20268-KReg FD DisclosureFeb 26, 2026
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance